Name | Description | Size | Catalog # | Supplier | |
---|---|---|---|---|---|
A-674563 | An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… | 500 µg | 18715-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 1 mg | 29972-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 10 mg | 29972-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 5 mg | 29972-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 500 µg | 29972-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 1 mg | 21256-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 10 mg | 21256-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 25 mg | 21256-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 5 mg | 21256-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-769662 | A direct activator of AMPK (EC50 = 116 nM in a cell-free assay); allosteri… | 10 mg | 11900-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-769662 | A direct activator of AMPK (EC50 = 116 nM in a cell-free assay); allosteri… | 25 mg | 11900-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-769662 | A direct activator of AMPK (EC50 = 116 nM in a cell-free assay); allosteri… | 5 mg | 11900-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-769662 | A direct activator of AMPK (EC50 = 116 nM in a cell-free assay); allosteri… | 50 mg | 11900-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-770041 | An orally bioavailable LCK kinase inhibitor (IC50 = 0.147 µM); selec… | 1 mg | 32854-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-770041 | An orally bioavailable LCK kinase inhibitor (IC50 = 0.147 µM); selec… | 5 mg | 32854-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-77-01 | A potent inhibitor of the TGF-β1 receptor ALK5 (IC550 = 25 nM), block… | 1 mg | 18396-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-77-01 | A potent inhibitor of the TGF-β1 receptor ALK5 (IC550 = 25 nM), block… | 10 mg | 18396-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-77-01 | A potent inhibitor of the TGF-β1 receptor ALK5 (IC550 = 25 nM), block… | 25 mg | 18396-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-77-01 | A potent inhibitor of the TGF-β1 receptor ALK5 (IC550 = 25 nM), block… | 5 mg | 18396-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-771726 | An active metabolite of leflunomide; inhibits DHODH (IC50 = 0.23 µM)… | 10 mg | 14404-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-771726 | An active metabolite of leflunomide; inhibits DHODH (IC50 = 0.23 µM)… | 25 mg | 14404-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-771726 | An active metabolite of leflunomide; inhibits DHODH (IC50 = 0.23 µM)… | 5 mg | 14404-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-784168 | A TRPV1 competitive antagonist; inhibits capsaicin-induced activation of T… | 1 mg | 32855-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-784168 | A TRPV1 competitive antagonist; inhibits capsaicin-induced activation of T… | 10 mg | 32855-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-784168 | A TRPV1 competitive antagonist; inhibits capsaicin-induced activation of T… | 25 mg | 32855-25 |
CAYMAN CHEMICAL COMPANY |
More Info |